CalciMedica Statistics
Share Statistics
CalciMedica has 13.48M shares outstanding. The number of shares has increased by 31.44% in one year.
| Shares Outstanding | 13.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 25.41% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.22M |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 72.58K, so 0.54% of the outstanding shares have been sold short.
| Short Interest | 72.58K |
| Short % of Shares Out | 0.54% |
| Short % of Float | 1% |
| Short Ratio (days to cover) | 1.68 |
Valuation Ratios
The PE ratio is -0.37 and the forward PE ratio is -2.14.
| PE Ratio | -0.37 |
| Forward PE | -2.14 |
| PS Ratio | 0 |
| Forward PS | 18.1 |
| PB Ratio | 1.57 |
| P/FCF Ratio | -0.5 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CalciMedica Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.
| Current Ratio | 2.88 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -4.21% and return on capital (ROIC) is -267.32%.
| Return on Equity (ROE) | -4.21% |
| Return on Assets (ROA) | -2.82% |
| Return on Capital (ROIC) | -267.32% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.64M |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -109.89K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -4.11% in the last 52 weeks. The beta is 0, so CalciMedica 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -4.11% |
| 50-Day Moving Average | 3.18 |
| 200-Day Moving Average | 4.26 |
| Relative Strength Index (RSI) | 47.39 |
| Average Volume (20 Days) | 62.38K |
Income Statement
| Revenue | n/a |
| Gross Profit | -58.00K |
| Operating Income | -21.88M |
| Net Income | -34.36M |
| EBITDA | -34.19M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -7.65 |
Balance Sheet
The company has 5.53M in cash and 0 in debt, giving a net cash position of 5.53M.
| Cash & Cash Equivalents | 5.53M |
| Total Debt | 0 |
| Net Cash | 5.53M |
| Retained Earnings | -146.06M |
| Total Assets | 16.21M |
| Working Capital | 11.90M |
Cash Flow
In the last 12 months, operating cash flow was -25.73M and capital expenditures -78.00K, giving a free cash flow of -25.81M.
| Operating Cash Flow | -25.73M |
| Capital Expenditures | -78.00K |
| Free Cash Flow | -25.81M |
| FCF Per Share | -5.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CALC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -233.94% |
| FCF Yield | -58.54% |
Analyst Forecast
The average price target for CALC is $18, which is 450.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $18 |
| Price Target Difference | 450.5% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Mar 20, 2023. It was a backward split with a ratio of 1:14.
| Last Split Date | Mar 20, 2023 |
| Split Type | backward |
| Split Ratio | 1:14 |
Scores
| Altman Z-Score | -13.33 |
| Piotroski F-Score | 1 |